Accelerate the adoption of your digital health solution
Speak to our expertsIllustration of a neural network linked to a mobile app showing a heart rate trace and data bars
Trusted by
The challenge
Only 1 in 5 digital health innovations that succeed in a pilot get adopted at scale. That's the gap we help close.
What we do
We generate the clinical and economic evidence you need and build the regulatory and reimbursement strategies that get your solution adopted, faster.
Clinical evidence
Win customers with robust, pragmatic evidence of safety and efficacy.
Learn moreabout Clinical evidenceEconomic evidence
Demonstrate the return on investment (ROI) of your solution to customers and decision-makers.
Learn moreabout Economic evidenceRegulatory
Identify and deliver the right strategy to obtain EU MDR, UK MDR and FDA regulatory approval.
Learn moreabout RegulatoryCommercialisation
Choose the right route to enter the market, price your solution and obtain reimbursement.
Learn moreabout Commercialisation
Why Prova Health
World-leading experts in digital health and AI
Pioneers in evidence generation methodologies for digital health and AI. Experts at navigating US, EU and UK regulatory and reimbursement pathways for digital health and AI solutions.
Global clinical expert network.
600+ healthcare insiders across 40+ countries power the proprietary Prova Health Network. Real clinical input keeps your evidence grounded in how care is actually delivered.
Health economics and real-world data expertise
Deep quantitative capability to build the economic case payers, providers and investors are looking for, validated end-to-end by practising clinicians.
Case studies
View all case studiesEvaluating Roche’s AI-enabled clinical decision support tool for oncologists, published in the Journal of Clinical Oncology (JCO)
Ran virtual simulation sessions with 27 oncologists based across the US, Singapore, Spain and the UK. Designed, delivered, and submitted results for publication in just 5 months.
Read the case study: Evaluating Roche’s AI-enabled clinical decision support tool for oncologists, published in the Journal of Clinical Oncology (JCO)Estimating cost savings from Microsoft AI's Diagnostic Orchestrator (MAI-DxO)
Advised on approach and methods to estimate cost savings from the newly developed MAI-DxO model. Estimated cost savings of up to 70%, due to the impact on physician visits and tests performed.
Read more: Estimating cost savings from Microsoft AI's Diagnostic Orchestrator (MAI-DxO)Evaluating Accurx's primary care booking tool to inform a national contract review
Engaged with 14 diverse primary care sites across the UK to conduct the evaluation and gather real-world data. Distributed over 14,000 patient surveys to collect extensive feedback on the Self-Book solution's usability and impact.
Read more: Evaluating Accurx's primary care booking tool to inform a national contract reviewDesigning and delivering the clinical validation study for Medwise, an AI clinical search engine
Conducted a clinical validation study with 30 primary care physicians. Robust, regulator-ready evidence to meet UKCA Class I standards.
Read more: Designing and delivering the clinical validation study for Medwise, an AI clinical search engineDesigning a clinical investigation protocol for the post-market EU MDR requirements of a Class IIb AI platform
Designed a multi-site clinical investigation to meet the post-market clinical evidence condition attached to the platform's Class IIb EU MDR CE mark. Delivered a regulator-ready clinical investigation protocol aligned with ISO 14155 and EU MDR clinical evidence requirements, in just six weeks.
Read more: Designing a clinical investigation protocol for the post-market EU MDR requirements of a Class IIb AI platform
Frequently asked questions
We work with digital health and AI of all sizes and stages of maturity. We help smaller startups secure non-dilutive funding (e.g., through grant applications) to pay for our services, if the right opportunity is available. We are a long-standing partner to some of the world's biggest digital health innovators.
Prova Health works with innovators in all areas of digital health, including AI-based solutions. We have supported innovative startups and scale-ups as well as established global leaders, such as Microsoft AI. We are experts at generating evidence and supporting market access for AI-based solutions. Read our white paper on evidence generation for AI solutions here.
Prova Health is headquartered in the UK and has an office in the US. A large proportion of our client base is in Switzerland. However, our work is truly global, having worked on projects in Germany, France, Spain, Italy, Canada, Brazil, Saudi Arabia, Japan and Australia (among many others).
Clinical simulation is an approach to evidence generation that Prova Health has pioneered and employed in numerous projects. It allows innovators to generate robust data about their solution's performance and impact much faster than other methodologies. Our customers have been able to use clinical simulation to provide evidence to healthcare providers and regulators. To learn more, read this PH Insights piece on innovative evidence generation methodologies.
In both pharma and digital health/AI our focus is on accelerating the adoption of innovation. The fact that we work across both innovation types is an added value for our clients. Digital health innovators benefit from our deep understanding of pharma as they consider go-to-market strategies and partnerships. Pharma companies benefit from our digital health expertise as they seek innovative ways to drive adoption of their therapies.